Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.57 |
| ▸ | DPP4 | P27487 | 2/20 | 0.56 |
| ▸ | SOS1 | Q07889 | 3/20 | 0.51 |
| ▸ | KRAS | P01116 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MPO | P05164 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30679614 | 0.94 | CAPN1 (0.55) | DPP3DPP4CAPN1CTSB | |
| SCHEMBL30051710 | 0.93 | DPP4 (0.54) | DPP3DPP4SOS1KRASCYP2C19 | |
| SCHEMBL29379873 | 0.91 | DPP4 (0.58) | DPP3DPP4SOS1KRASCYP2C19 | |
| SCHEMBL30051339 | 0.89 | DPP4 (0.58) | DPP3DPP4SOS1KRASCYP2C19 | |
| SCHEMBL29572021 | 0.88 | DPP3 (0.71) | DPP3MEN1KMT2A | |
| SCHEMBL30051839 | 0.88 | DPP4 (0.54) | DPP3DPP4SOS1KRASCYP2C19 | |
| SCHEMBL29973443 | 0.87 | DPP3 (0.57) | DPP3DPP4SOS1KRASCAPN1 | |
| SCHEMBL31326865 | 0.87 | CAPN1 (0.52) | DPP3CAPN1CTSB | |
| SCHEMBL30051395 | 0.86 | DPP3 (0.59) | DPP3DPP4SOS1KRAS | |
| SCHEMBL30311085 | 0.86 | DPP4 (0.56) | DPP3DPP4SOS1KRASCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| CN-119350437-A | Xanthine oxidase inhibitory peptide of tuna of source Yu Qinggan and application thereof | 中国海洋大学三亚海洋研究院 | 2025-01-24 | — | — | CN | disclosed |
| CN-116874567-A | Sponge cyclic peptide compound and preparation method and application thereof | 上海交通大学医学院附属仁济医院 | 2023-10-13 | — | — | CN | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | DPP3 25/4885DPP4 43/4885SOS1 2868/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | DPP3 64/4885DPP4 73/4885SOS1 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.